Surging Storm Therapeutics Secures $56M for Sarcoma Drug.

Clinical Research Updates: Pancreatic Cancer Phase 3 Plans, Sarcoma Funding & Precision Oncology Momentum

Clinical research continues to accelerate through pivotal trial planning, major biotech financing rounds, and promising precision oncology developments. Recent updates…